Robert Jacks

Robert Jacks

Algemeen Directeur bij
Sparrow Pharmaceuticals, Inc.
Health Technology
Consumer Services
Finance

Profiel

Robert Jacks was the founder of Symbiomix Therapeutics LLC, founded in 2012, holding the title of President & Chief Financial Officer.
Mr. Jacks is currently the President, Chief Executive Officer & Director at Sparrow Pharmaceuticals, Inc. since 2021.
Former positions include President, Chief Executive Officer & Director at Indalo Therapeutics, Inc., Principal at Pfizer Inc., Vice President-Business Development at Paramount BioSciences LLC, and Vice President & Head-Development at ACT Biotech, Inc. Education includes an undergraduate degree from Duke University, a graduate degree from Stanford University, and an MBA from Columbia Business School.

Actieve functies van Robert Jacks

BedrijvenFunctieBegin
Algemeen Directeur 01-01-2021

Eerdere bekende functies van Robert Jacks

BedrijvenFunctieEinde
Algemeen Directeur -
Oprichter -
Corporate Officer/Principal -
PFIZER INC. Corporate Officer/Principal -
Private Equity Investor -
Ervaring van Robert Jacks in detail bekijken

Opleiding van Robert Jacks

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Robert Jacks
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU